Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 4 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Solid Tumor 1 Skin Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Inflammatory Breast Neoplasms 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Craniopharyngioma 1 Cholangiocarcinoma 1 Carcinosarcoma 1 Brain Neoplasms 1

Interventions

pembrolizumab 3 zimberelimab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 encorafenib 1 cobimetinib 1 cedazuridine 1 binimetinib 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × cobimetinib × Clear all

NCT04185831 2024-08-22

MEGALiT

Uppsala University Hospital

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡